GI CONNECT review paper published in Annals of Oncology

Four GI CONNECT members authored a paper ‘Challenging Chemoresistant Metastatic Colorectal cancer: therapeutic strategies from the clinic and from the laboratory’ with the aim to review the effective and well-tolerated third-line and subsequent lines of treatment; and to exploit oncogenic drivers of colorectal cancer and overcome acquired resistance.

selected_highlights_challenging_chemoresistant_mcrc_therapeutic_strategies_from_the_clinic_and_from_the_lab-1-1

 

GI CONNECT is an initiative of COR2ED – A company in independent medical education

GI CONNECT is supported by an Independent Educational Grant from Bayer

The material and content contained in this GI CONNECT website are for healthcare professionals only. Although every effort is made to ensure that the material within this website is accurate and timely, it is provided for informational and educational purposes only. The information provided is not intended as a substitute for medical professional help, advice, diagnosis or treatment and may not be applicable to every case or country. The views of GI CONNECT members expressed on this website do not reflect those of their academic institutions or establishments. 

Privacy Policy

Copyright COR2ED - contact 

Design / Dev: AM — Portraits illustrations: STPo - Powered by: Healios Tech Healios Tech - Web and App design and development for health industry